You are on page 1of 9

Scopus - Document details

8/17/13 4:39 AM

Hub

ScienceDirect

Scopus

Applications

Register

Login

Go to SciVal Suite

Brought to you by University of Connecticut Libraries

Search

Sources

Analytics

Alerts
Search

My list

Settings

Live Chat

Help

Tutorials

Quick Search
Back to results | 1 of 1

| Molecular Pharmaceutics

| View at Publisher |

Export

Print

E-mail

Create bibliography

Add to My List

Cited by since 1996


This article has been cited 594 times in Scopus:
(Showing the 2 most recent)

Volume 4, Issue 6, November 2007, Pages 807-818

Bioavailability of curcumin: Problems and promises


Anand, P.a, Kunnumakkara, A.B.a, Newman, R.A.b, Aggarwal, B.B.ac
a

( Review )

Sun, J. , Bi, C. , Chan, H.M.

Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability
(2013) Colloids and Surfaces B: Biointerfaces Nambiar, D. , Singh, R.P.

Cytokine Research Laboratory, Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, United

States
b

Pharmaceutical Development Center, Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030,

United States
c

Advances in prostate cancer chemoprevention: A translational perspective


(2013) Nutrition and Cancer

Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Center, Box 143, 1515 Holcombe Blvd, Houston, TX 77030, United

States View references (85)

View details of all 594 citations Inform me when this document is cited in Scopus:
Set alert | Set feed

Abstract

Curcumin, a polyphenolic compound derived from dietary spice turmeric, possesses diverse pharmacologic effects including antiinflammatory, antioxidant, antiproliferative and antiangiogenic activities. Phase I clinical trials have shown that curcumin is safe even at high doses (12 g/day) in humans but exhibit poor bioavailability. Major reasons contributing to the low plasma and tissue levels of curcumin appear to be due to poor absorption, rapid metabolism, and rapid systemic elimination. To improve the bioavailability of curcumin, numerous approaches have been undertaken. These approaches involve, first, the use of adjuvant like pipeline that interferes with glucuronidation; second, the use of liposomal curcumin; third, curcumin nanoparticles; fourth, the use of curcumin phospholipid complex; and fifth, the use of structural analogues of curcumin (e.g., EF-24). The latter has been reported to have a rapid absorption with a peak plasma half-life. Despite the lower bioavailability, therapeutic efficacy of curcumin against various human diseases, including cancer, cardiovascular diseases, diabetes, arthritis, neurological diseases and Crohn's disease, has been documented. Enhanced bioavailability of curcumin in the near future is likely to bring this promising natural product to the forefront of therapeutic agents for treatment of human disease. 2007 American Chemical Society.
Find more related documents in Scopus based on: Authors | Keywords

Related documents

Author keywords
Absorption; Adjuvants; Bioavailability; Biocurcumax; Curcumin; Formulations; Metabolism; Nanoparticles

Indexed keywords
EMTREE drug terms: antineoplastic agent; biocurcumax; boron; cadmium; copper; curcumin; curcumin glucuronide derivative; dihydrocurcumin; ef 24; epigallocatechin gallate; eugenol; gallium; genistein; glucuronide; hexahydrocurcumin; indium; liposome; manganese; nanoparticle; oxaliplatin; phospholipid; piperine; placebo; quercetin; terpene derivative; terpeneol; tetrahydrocurcumin; unclassified drug; vanadyl derivative EMTREE medical terms: adenomatous polyp; adjuvant therapy; area under the curve; arthritis; carcinoma cell; cardiovascular disease; clinical trial; colorectal cancer; combination chemotherapy; complex formation; Crohn disease; diabetes mellitus; drug absorption; drug bioavailability; drug blood level; drug dosage form comparison; drug efficacy; drug elimination; drug half life; drug megadose; drug metabolism; drug potentiation; drug structure; drug tissue level; glucuronidation; human; micelle; monotherapy; neoplasm; neurologic disease; nonhuman; priority journal; review; single drug dose; unspecified side effect MeSH: Animals; Biological Availability; Curcumin; Drug Delivery Systems; Humans; Tissue Distribution Medline is the source for the MeSH terms of this document. Chemicals and CAS Registry Numbers: boron, 7440-42-8; cadmium, 22537-48-0, 7440-43-9; copper, 15158-11-9, 7440-50-8; curcumin, 458-37-7; epigallocatechin gallate, 989-51-5; eugenol, 97-53-0; gallium, 7440-55-3; genistein, 446-72-0; indium, 7440-746; manganese, 16397-91-4, 7439-96-5; oxaliplatin, 61825-94-3; piperine, 94-62-2; quercetin, 117-39-5;Curcumin, 458-37-7 Drug tradename: ef 24.
ISSN: 15438384 Source Type: Journal Original language: English Document Type: Review View in table layout

DOI: 10.1021/mp700113r

PubMed ID: 17999464

References (85)
First 80 references displayed (View all references)

https://vpn.uconn.edu/record/,DanaInfo=www.scopus.com+display.uot=b&sdt=b&sl=36&s=TITLE-ABS-KEY%28%22SMEDDS%22+and+curcumin%29

Page 1 of 9

Scopus - Document details

8/17/13 4:39 AM

Page

Export

Print

E-mail

Create bibliography

Aggarwal, B.B., Kumar, A., Bharti, A.C.


1

Anticancer potential of curcumin: Preclinical and clinical studies


(2003) Anticancer Research, 23 (1 A), pp. 363-398. Cited 953 times.

Sharma, O.P.
2

Antioxidant activity of curcumin and related compounds


(1976) Biochemical Pharmacology, 25 (15), pp. 1811-1812. Cited 402 times. doi: 10.1016/0006-2952(76)90421-4
View at Publisher

Ruby, A.J., Kuttan, G., Dinesh Babu, K., Rajasekharan, K.N., Kuttan, R.
3

Anti-tumour and antioxidant activity of natural curcuminoids


(1995) Cancer Letters, 94 (1), pp. 79-83. Cited 472 times.
View at Publisher

Sugiyama, Y., Kawakishi, S., Osawa, T.


4

Involvement of the -diketone moiety in the antioxidative mechanism of tetrahydrocurcumin


(1996) Biochemical Pharmacology, 52 (4), pp. 519-525. Cited 195 times. doi: 10.1016/0006-2952(96)00302-4
View at Publisher

Srimal, R.C., Dhawan, B.N.


5

Pharmacology of diferuloyl methane (curcumin), a non steroidal anti inflammatory agent


(1973) Journal of Pharmacy and Pharmacology, 25 (6), pp. 447-452. Cited 299 times.
View at Publisher

Jordan, W.C., Drew, C.R.


6

Curcumin--a natural herb with anti-HIV activity.


(1996) Journal of the National Medical Association, 88 (6), p. 333. Cited 30 times.

Mahady, G. B.; Pendland, S. L.; Yun, G; Lu, Z. Z. Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter 7 pylori, a group 1 carcinogen. Anticancer Res. 2002, 22 (6C), 4179-81.

Kim, M.-K., Choi, G.-J., Lee, H.-S.


8

Fungicidal property of Curcuma longa L. rhizome-derived curcumin against phytopathogenic fungi in a greenhouse
(2003) Journal of Agricultural and Food Chemistry, 51 (6), pp. 1578-1581. Cited 54 times. doi: 10.1021/jf0210369
View at Publisher

Reddy, R.C., Vatsala, P.G., Keshamouni, V.G., Padmanaban, G., Rangarajan, P.N.
9

Curcumin for malaria therapy


(2005) Biochemical and Biophysical Research Communications, 326 (2), pp. 472-474. Cited 88 times. doi: 10.1016/j.bbrc.2004.11.051
View at Publisher

Kuttan, R., Bhanumathy, P., Nirmala, K., George, M.C.


10

Potential anticancer activity of turmeric (Curcuma longa)


(1985) Cancer Letters, 29 (2), pp. 197-202. Cited 230 times.
View at Publisher

Kiso, Y., Suzuki, Y., Watanabe, N., Oshima, Y., Hikino, H.


11

Antihepatotoxic principles of Curcuma longa rhizomes


(1983) Planta Medica, 49 (3), pp. 185-187. Cited 88 times.
View at Publisher

Venkatesan, N.Curcumin attenuation of acute adriamycin myocardial toxicity in rats. Br. J. Pharmacol. 1998, 124 (3), 425-7. 12

https://vpn.uconn.edu/record/,DanaInfo=www.scopus.com+display.uot=b&sdt=b&sl=36&s=TITLE-ABS-KEY%28%22SMEDDS%22+and+curcumin%29

Page 2 of 9

Scopus - Document details

8/17/13 4:39 AM

Venkatesan, N., Punithavathi, D., Arumugam, V.


13

Curcumin prevents adriamycin nephrotoxicity in rats


(2000) British Journal of Pharmacology, 129 (2), pp. 231-234. Cited 76 times.
View at Publisher

Srivastava, R., Dikshit, M., Srimal, R.C., Dhawan, B.N.


14

Anti-thrombotic effect of curcumin


(1985) Thrombosis Research, 40 (3), pp. 413-417. Cited 69 times.
View at Publisher

Dikshit, M., Rastogi, L., Shukla, R., Srimal, R.C.


15

Prevention of ischaemia-induced biochemical changes by curcumin and quinidine in the cat heart
(1995) Indian Journal of Medical Research, 101 (JAN.), pp. 31-35. Cited 58 times.

Nirmala, C., Puvanakrishnan, R.


16

Protective role of curcumin against isoproterenol induced myocardial infarction in rats


(1996) Molecular and Cellular Biochemistry, 159 (2), pp. 85-93. Cited 117 times. doi: 10.1007/BF00420910
View at Publisher

Nirmala, C., Puvanakrishnan, R.


17

Effect of curcumin on cetrain lysosomal hydrolases in isoproterenol-induced myocardial infarction in rats


(1996) Biochemical Pharmacology, 51 (1), pp. 47-51. Cited 51 times. doi: 10.1016/0006-2952(95)02118-3
View at Publisher

Srinivasan, M.
18

Effect of curcumin on blood sugar as seen in a diabetic subject.


(1972) Indian Journal of Medical Sciences, 26 (4), pp. 269-270. Cited 37 times.

Babu, P.S., Srinivasan, K.


19

Influence of dietary curcumin and cholesterol on the progression of experimentally induced diabetes in albino rat
(1995) Molecular and Cellular Biochemistry, 152 (1), pp. 13-21. Cited 53 times.

Suresh Babu, P., Srinivasan, K.


20

Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats
(1997) Molecular and Cellular Biochemistry, 166 (1-2), pp. 169-175. Cited 137 times. doi: 10.1023/A:1006819605211
View at Publisher

Arun, N., Nalini, N.


21

Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats
(2002) Plant Foods for Human Nutrition, 57 (1), pp. 41-52. Cited 135 times. doi: 10.1023/A:1013106527829
View at Publisher

Deodhar, S.D., Sethi, R., Srimal, R.C.


22

Preliminary study on antirheumatic activity of curcumin (diferuloyl methane)


(1980) Indian Journal of Medical Research, 71 (4), pp. 632-634. Cited 162 times.

Shankar, T.N., Shantha, N.V., Ramesh, H.P., Murthy, I.A., Murthy, V.S.
23

Toxicity studies on turmeric (Curcuma longa): Acute toxicity studies in rats, guinea pigs & monkeys
(1980) Indian Journal of Experimental Biology, 18 (1), pp. 73-75. Cited 80 times.

Qureshi, S., Shah, A.H., Ageel, A.M.


24

Toxicity studies on Alpinia galanga and Curcuma longa

https://vpn.uconn.edu/record/,DanaInfo=www.scopus.com+display.uot=b&sdt=b&sl=36&s=TITLE-ABS-KEY%28%22SMEDDS%22+and+curcumin%29

Page 3 of 9

Scopus - Document details

8/17/13 4:39 AM

(1992) Planta Medica, 58 (2), pp. 124-127. Cited 46 times.


View at Publisher

Lao, C.D., Demierre, M.-F., Sondak, V.K.


25

Targeting events in melanoma carcinogenesis for the prevention of melanoma


(2006) Expert Review of Anticancer Therapy, 6 (11), pp. 1559-1568. Cited 28 times.
http://www.future-drugs.com/doi/pdf/10.1586/14737140.6.11.1559

doi: 10.1586/14737140.6.11.1559
View at Publisher

Lao, C.D., Ruffin IV, M.T., Normolle, D., Heath, D.D., Murray, S.I., Bailey, J.M., Boggs, M.E., (...), Brenner, D.E.
26

Dose escalation of a curcuminoid formulation


(2006) BMC Complementary and Alternative Medicine, 6, art. no. 10, pp. 4. Cited 231 times.
http://www.biomedcentral.com/1472-6882/6/10

doi: 10.1186/1472-6882-6-10
View at Publisher

Cheng, A. L.; Hsu, C. H.; Lin, J. K.; Hsu, M. M.; Ho, Y. F.; Shen, T. S.; Ko, J. Y.; Lin, J. T.; Lin, B. R.; Ming-Shiang, W; Yu, H. 27 S.; Jee, S. H.; Chen, G. S.; Chen, T. M.; Chen, C. A.; Lai, M. K.; Pu, Y. S.; Pan, M. H.; Wang, Y. J.; Tsai, C. C.; Hsieh, C. Y. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001, 21 (4B), 2895-900.

Shoba, G., Joy, D., Joseph, T., Majeed, M., Rajendran, R., Srinivas, P.S.S.R.
28

Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers


(1998) Planta Medica, 64 (4), pp. 353-356. Cited 420 times. doi: 10.1055/s-2006-957450
View at Publisher

Aggarwal, B.B., Sundaram, C., Malani, N., Ichikawa, H.


29

Curcumin: The Indian solid gold


(2007) Advances in Experimental Medicine and Biology, 595, pp. 1-75. Cited 323 times. ISBN: 978-038746400-8 doi: 10.1007/978-0-387-46401-5-1
View at Publisher

Hsu, C.-H., Cheng, A.-L.


30

Clinical studies with curcumin


(2007) Advances in Experimental Medicine and Biology, 595, pp. 471-480. Cited 134 times. ISBN: 978-038746400-8 doi: 10.1007/978-0-387-46401-5-21
View at Publisher

Wahlstrom, B., Blennow, G.


31

A study on the fate of curcumin in the rat


(1978) Acta Pharmacologica et Toxicologica, 43 (2), pp. 86-92. Cited 168 times.
View at Publisher

Ravindranath, V., Chandrasekhara, N.


32

Absorption and tissue distribution of curcumin in rats


(1980) Toxicology, 16 (3), pp. 259-265. Cited 168 times. doi: 10.1016/0300-483X(80)90122-5
View at Publisher

Ravindranath, V., Chandrasekhara, N.


33

Metabolism of curcumn-studies with [3H]curcumin


(1981) Toxicology, 22 (4), pp. 337-344. Cited 104 times.
View at Publisher

Pan, M.-H., Huang, T.-M., Lin, J.-K.


34

Biotransformation of curcumin through reduction and glucuronidation in mice


(1999) Drug Metabolism and Disposition, 27 (4), pp. 486-494. Cited 301 times.
View at Publisher

Perkins, S., Verschoyle, R.D., Hill, K., Parveen, I., Threadgill, M.D., Sharma, R.A., Williams, M.L., (...), Gescher, A.J.

https://vpn.uconn.edu/record/,DanaInfo=www.scopus.com+display.uot=b&sdt=b&sl=36&s=TITLE-ABS-KEY%28%22SMEDDS%22+and+curcumin%29

Page 4 of 9

Scopus - Document details

8/17/13 4:39 AM

35

Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis
(2002) Cancer Epidemiology Biomarkers and Prevention, 11 (6), pp. 535-540. Cited 154 times.
View at Publisher

Sharma, R. A.; Euden, S. A.; Platten, S. L.; Cooke, D. N.; Shafayat, A; Hewitt, H. R.; Marczylo, T. H.; Morgan, B.; Hemingway, 36 D.; Plummer, S. M.; Pirmohamed, M; Gescher, A. J.; Steward, W. P. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin. Cancer Res. 2004, 10 (20), 6847-54.

Yang, K.-Y., Lin, L.-C., Tseng, T.-Y., Wang, S.-C., Tsai, T.-H.
37

Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS
(2007) Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 853 (1-2), pp. 183189. Cited 80 times. doi: 10.1016/j.jchromb.2007.03.010
View at Publisher

Maiti, K., Mukherjee, K., Gantait, A., Saha, B.P., Mukherjee, P.K.
38

Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats


(2007) International Journal of Pharmaceutics, 330 (1-2), pp. 155-163. Cited 196 times. doi: 10.1016/j.ijpharm.2006.09.025
View at Publisher

Marczylo, T. H.; Verschoyle, R. D.; Cooke, D. N.; Morazzoni, P; Steward, W. P.; Gescher, A. J. Comparison of systemic 39 availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother. Pharmacol. 2007, 60 (2), 171-7.

Ravindranath, V., Chandrasekhara, N.


40

In vitro studies on the intestinal absorption of curcumin in rats


(1981) Toxicology, 20 (2-3), pp. 251-257. Cited 70 times.
View at Publisher

Garcea, G., Jones, D.J.L., Singh, R., Dennison, A.R., Farmer, P.B., Sharma, R.A., Steward, W.P., (...), Berry, D.P.
41

Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration
(2004) British Journal of Cancer, 90 (5), pp. 1011-1015. Cited 162 times. doi: 10.1038/sj.bjc.6601623
View at Publisher

Garcea, G., Berry, D.P., Jones, D.J.L., Singh, R., Dennison, A.R., Farmer, P.B., Sharma, R.A., (...), Gescher, A.J.
42

Consumption of the putative chemopreventive agent curcumin by cancer patients: Assessment of curcumin levels in the colorectum and their pharmacodynamic consequences
(2005) Cancer Epidemiology Biomarkers and Prevention, 14 (1), pp. 120-125. Cited 156 times.
View at Publisher

Hoehle, S.I., Pfeiffer, E., Slyom, A.M., Metzler, M.


43

Metabolism of curcuminoids in tissue slices and subcellular fractions from rat liver
(2006) Journal of Agricultural and Food Chemistry, 54 (3), pp. 756-764. Cited 37 times. doi: 10.1021/jf058146a
View at Publisher

Holder, G.M., Plummer, J.L., Ryan, A.J.


44

The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat


(1978) Xenobiotica, 8 (12), pp. 761-768. Cited 114 times.
View at Publisher

Ireson, C., Orr, S., Jones, D.J.L., Verschoyle, R., Lim, C.-K., Luo, J.-L., Howells, L., (...), Gescher, A.
45

Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production
(2001) Cancer Research, 61 (3), pp. 1058-1064. Cited 226 times.
View at Publisher

Asai, A., Miyazawa, T.

https://vpn.uconn.edu/record/,DanaInfo=www.scopus.com+display.uot=b&sdt=b&sl=36&s=TITLE-ABS-KEY%28%22SMEDDS%22+and+curcumin%29

Page 5 of 9

Scopus - Document details

8/17/13 4:39 AM

46

Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma
(2000) Life Sciences, 67 (23), pp. 2785-2793. Cited 89 times.
View at Publisher

Hoehle, S.I., Pfeiffer, E., Metzler, M.


47

Glucuronidation of curcuminoids by human microsomal and recombinant UDP-glucuronosyltransferases


(2007) Molecular Nutrition and Food Research, 51 (8), pp. 932-938. Cited 22 times. doi: 10.1002/mnfr.200600283
View at Publisher

Sandur, S.K., Pandey, M.K., Sung, B., Ahn, K.S., Murakami, A., Sethi, G., Limtrakul, P., (...), Aggarwal, B.B.
48

Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism
(2007) Carcinogenesis, 28 (8), pp. 1765-1773. Cited 118 times. doi: 10.1093/carcin/bgm123
View at Publisher

Pfeiffer, E., Hoehle, S.I., Walch, S.G., Riess, A., Slyom, A.M., Metzler, M.
49

Curcuminoids form reactive glucuronides in vitro


(2007) Journal of Agricultural and Food Chemistry, 55 (2), pp. 538-544. Cited 31 times. doi: 10.1021/jf0623283
View at Publisher

Kim, J.M., Araki, S., Kim, D.J., Park, C.B., Takasuka, N., Baba-Toriyama, H., Ota, T., (...), Tsuda, H.
50

Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1,2dimethylhydrazine initiation
(1998) Carcinogenesis, 19 (1), pp. 81-85. Cited 165 times. doi: 10.1093/carcin/19.1.81
View at Publisher

Okada, K., Wangpoengtrakul, C., Tanaka, T., Toyokuni, S., Uchida, K., Osawa, T.
51

Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice
(2001) Journal of Nutrition, 131 (8), pp. 2090-2095. Cited 108 times.
View at Publisher

Naito, M., Wu, X., Nomura, H., Kodama, M., Kato, Y., Kato, Y., Osawa, T.
52

The protective effects of tetrahydrocurcumin on oxidative stress in cholesterol-fed rabbits.


(2002) Journal of atherosclerosis and thrombosis, 9 (5), pp. 243-250. Cited 48 times.
View at Publisher

Pari, L., Amali, D.R.


53

Protective role of tetrahydrocurcumin (THC) an active principle of turmeric on chloroquine induced hepatotoxicity in rats
(2005) Journal of Pharmacy and Pharmaceutical Sciences, 8 (1), pp. 115-123. Cited 47 times.
http://www.ualberta.ca/~csps/JPPS8(1)/L.Pari/thc.htm View at Publisher

Murugan, P., Pari, L.


54

Effect of tetrahydrocurcumin on plasma antioxidants in streptozotocin- nicotinamide experimental diabetes


(2006) Journal of Basic and Clinical Physiology and Pharmacology, 17 (4), pp. 231-244. Cited 11 times.

55

Sharma, R.A., McLelland, H.R., Hill, K.A., Ireson, C.R., Euden, S.A., Manson, M.M., Pirmohamed, M., (...), Steward, W.P. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer
(2001) Clinical Cancer Research, 7 (7), pp. 1894-1900. Cited 305 times.
View at Publisher

Ryu, E.K., Choe, Y.S., Lee, K.-H., Choi, Y., Kim, B.-T.
56

Curcumin and dehydrozingerone derivatives: Synthesis, radiolabeling, and evaluation for -amyloid plaque imaging
(2006) Journal of Medicinal Chemistry, 49 (20), pp. 6111-6119. Cited 62 times. doi: 10.1021/jm0607193
View at Publisher

https://vpn.uconn.edu/record/,DanaInfo=www.scopus.com+display.uot=b&sdt=b&sl=36&s=TITLE-ABS-KEY%28%22SMEDDS%22+and+curcumin%29

Page 6 of 9

Scopus - Document details

8/17/13 4:39 AM

Cruz-Correa, M., Shoskes, D.A., Sanchez, P., Zhao, R., Hylind, L.M., Wexner, S.D., Giardiello, F.M.
57

Combination Treatment With Curcumin and Quercetin of Adenomas in Familial Adenomatous Polyposis
(2006) Clinical Gastroenterology and Hepatology, 4 (8), pp. 1035-1038. Cited 110 times. doi: 10.1016/j.cgh.2006.03.020
View at Publisher

Verma, S.P., Salamone, E., Goldin, B.


58

Curcumin and genistein, plant natural products, show synergistic inhibitory effects on the growth of human breast cancer MCF-7 cells induced by estrogenic pesticides
(1997) Biochemical and Biophysical Research Communications, 233 (3), pp. 692-696. Cited 74 times. doi: 10.1006/bbrc.1997.6527
View at Publisher

Fang, J.Y., Hung, C.F., Chiu, H.C., Wang, J.J., Chan, T.F.
59

Efficacy and irritancy of enhancers on the in-vitro and in-vivo percutaneous absorption of curcumin.
(2003) The Journal of pharmacy and pharmacology, 55 (8), p. 1175. Cited 7 times.
View at Publisher

Balasubramanian, S., Eckert, R.L.


60

Green tea polyphenol and curcumin inversely regulate human involucrin promoter activity via opposing effects on CCAAT/enhancer-binding protein function
(2004) Journal of Biological Chemistry, 279 (23), pp. 24007-24014. Cited 45 times. doi: 10.1074/jbc.M314331200
View at Publisher

Bisht, S., Feldmann, G., Soni, S., Ravi, R., Karikar, C., Maitra, A., Maitra, A.
61

Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): A novel strategy for human cancer therapy
(2007) Journal of Nanobiotechnology, 5, art. no. 3. Cited 248 times. doi: 10.1186/1477-3155-5-3
View at Publisher

Tiyaboonchai, W., Tungpradit, W., Plianbangchang, P.


62

Formulation and characterization of curcuminoids loaded solid lipid nanoparticles


(2007) International Journal of Pharmaceutics, 337 (1-2), pp. 299-306. Cited 108 times. doi: 10.1016/j.ijpharm.2006.12.043
View at Publisher

Li, L., Braiteh, F.S., Kurzrock, R.


63

Liposome-encapsulated curcumin: In vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis
(2005) Cancer, 104 (6), pp. 1322-1331. Cited 195 times. doi: 10.1002/cncr.21300
View at Publisher

Li, L., Ahmed, B., Mehta, K., Kurzrock, R.


64

Liposomal curcumin with and without oxaliplatin: Effects on cell growth, apoptosis, and angiogenesis in colorectal cancer
(2007) Molecular Cancer Therapeutics, 6 (4), pp. 1276-1282. Cited 102 times. doi: 10.1158/1535-7163.MCT-06-0556
View at Publisher

Kunwar, A., Barik, A., Pandey, R., Priyadarsini, K.I.


65

Transport of liposomal and albumin loaded curcumin to living cells: An absorption and fluorescence spectroscopic study
(2006) Biochimica et Biophysica Acta - General Subjects, 1760 (10), pp. 1513-1520. Cited 88 times. doi: 10.1016/j.bbagen.2006.06.012
View at Publisher

Suresh, D., Srinivasan, K.


66

Studies on the in vitro absorption of spice principles - Curcumin, capsaicin and piperine in rat intestines
(2007) Food and Chemical Toxicology, 45 (8), pp. 1437-1442. Cited 39 times. doi: 10.1016/j.fct.2007.02.002
View at Publisher

https://vpn.uconn.edu/record/,DanaInfo=www.scopus.com+display.uot=b&sdt=b&sl=36&s=TITLE-ABS-KEY%28%22SMEDDS%22+and+curcumin%29

Page 7 of 9

Scopus - Document details

8/17/13 4:39 AM

Ma, Z., Shayeganpour, A., Brocks, D.R., Lavasanifar, A., Samuel, J.


67

High-performance liquid chromatography analysis of curcumin in rat plasma: Application to pharmacokinetics of polymeric micellar formulation of curcumin
(2007) Biomedical Chromatography, 21 (5), pp. 546-552. Cited 60 times. doi: 10.1002/bmc.795
View at Publisher

Gatti, G., Perucca, E.


68

Plasma concentrations of free and conjugated silybin after oral intake of a silybin-phosphatidylcholine complex (silipide) in healthy volunteers
(1994) International Journal of Clinical Pharmacology and Therapeutics, 32 (11), pp. 614-617. Cited 56 times.

Kimura, T., Takeda, K., Kageyu, A., Toda, M., Kurosaki, Y., Nakayama, T.
69

Intestinal absorption of dolichol from emulsions and liposomes in rats


(1989) Chemical and Pharmaceutical Bulletin, 37 (2), pp. 463-466. Cited 12 times.

Liu, A., Lou, H., Zhao, L., Fan, P.


70

Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin
(2006) Journal of Pharmaceutical and Biomedical Analysis, 40 (3), pp. 720-727. Cited 73 times. doi: 10.1016/j.jpba.2005.09.032
View at Publisher

Letchford, K., Liggins, R., Burt, H.


71 (2007) J. Pharm. Sci

Shen, L., Ji, H.-F.


72

Theoretical study on physicochemical properties of curcumin


(2007) Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 67 (3-4), pp. 619-623. Cited 57 times. doi: 10.1016/j.saa.2006.08.018
View at Publisher

Mosley, C.A., Liotta, D.C., Snyder, J.P.


73

Highly active anticancer curcumin analogues


(2007) Advances in Experimental Medicine and Biology, 595, pp. 77-103. Cited 50 times. ISBN: 978-038746400-8 doi: 10.1007/978-0-387-46401-5-2
View at Publisher

Preetha, A., Banerjee, R., Huilgol, N.


74

Tensiometric profiles and their modulation by cholesterol: Implications in cervical cancer


(2007) Cancer Investigation, 25 (3), pp. 172-181. Cited 5 times. doi: 10.1080/07357900701209053
View at Publisher

Ohori, H., Yamakoshi, H., Tomizawa, M., Shibuya, M., Kakudo, Y., Takahashi, A., Takahashi, S., (...), Shibata, H.
75

Synthesis and biolgical analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer
(2006) Molecular Cancer Therapeutics, 5 (10), pp. 2563-2571. Cited 66 times. doi: 10.1158/1535-7163.MCT-06-0174
View at Publisher

John, V.D., Kuttan, G., Krishnankutty, K.


76

Anti-tumour studies of metal chelates of synthetic curcuminoids


(2002) Journal of Experimental and Clinical Cancer Research, 21 (2), pp. 219-224. Cited 49 times.

Sui, Z., Salto, R., Li, J., Craik, C., Ortiz de Montellano, P.R.
77

Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes
(1993) Bioorganic and Medicinal Chemistry, 1 (6), pp. 415-422. Cited 92 times.

https://vpn.uconn.edu/record/,DanaInfo=www.scopus.com+display.uot=b&sdt=b&sl=36&s=TITLE-ABS-KEY%28%22SMEDDS%22+and+curcumin%29

Page 8 of 9

Scopus - Document details

8/17/13 4:39 AM

View at Publisher

Eybl, V., Kotyzov, D., Leetick, L., Bludovsk, M., Koutensk, J.


78

The influence of curcumin and manganese complex of curcumin on cadmium-induced oxidative damage and trace elements status in tissues of mice
(2006) Journal of Applied Toxicology, 26 (3), pp. 207-212. Cited 20 times. doi: 10.1002/jat.1124
View at Publisher

Vajragupta, O., Boonchoong, P., Watanabe, H., Tohda, M., Kummasud, N., Sumanont, Y.
79

Manganese complexes of curcumin and its derivatives: Evaluation for the radical scavenging ability and neuroprotective activity
(2003) Free Radical Biology and Medicine, 35 (12), pp. 1632-1644. Cited 81 times. doi: 10.1016/j.freeradbiomed.2003.09.011
View at Publisher

Vajragupta, O., Boonchoong, P., Berliner, L.J.


80

Manganese complexes of curcumin analogues: Evaluation of hydroxyl radical scavenging ability, superoxide dismutase activity and stability towards hydrolysis
(2004) Free Radical Research, 38 (3), pp. 303-314. Cited 41 times. doi: 10.1080/10715760310001643339
View at Publisher

First 80 references displayed (View all references) Aggarwal, B.B.; Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Center, Box 143, 1515 Holcombe Blvd, Houston, TX 77030, United States; email:aggarwal@mdanderson.org Copyright 2009 Elsevier B.V., All rights reserved. MEDLINE is the source for the MeSH terms of this document.
Back to results | 1 of 1

Top of page
Language Customer Service Contact and support Live Chat About Elsevier Terms and Conditions Privacy Policy

About Scopus What is Scopus Content coverage

Copyright 2013 Elsevier B.V. All rights reserved. SciVerse is a registered trademark of Elsevier Properties S.A., used under license. Scopus is a registered trademark of Elsevier B.V. Cookies are set by this site. To decline them or learn more, visit our Cookies page.

https://vpn.uconn.edu/record/,DanaInfo=www.scopus.com+display.uot=b&sdt=b&sl=36&s=TITLE-ABS-KEY%28%22SMEDDS%22+and+curcumin%29

Page 9 of 9

You might also like